Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $35.6000 (-1.79%) ($35.6000 - $36.3000) on Mon. May. 9, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.57% (three month average) | RSI | 61 | Latest Price | $35.6000(-1.79%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.6% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) EWG(7%) EWI(7%) IVE(7%) PEJ(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.785% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-5%) SLV(-4%) GDX(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.785% (StdDev 5.57%) | Hourly BBV | 0 () | Intraday Trend | -1.1% | | | |
|
Resistance Level | $36.23 | 5 Day Moving Average | $37.1(-4.04%) | 10 Day Moving Average | $37.7(-5.57%) | 20 Day Moving Average | $36.23(-1.74%) | To recent high | -14.6% | To recent low | 69.5% | Market Cap | $701m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |